Georgialee Gould
Primary Care · New Cumberland, PANPI 1316602790
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 338 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 17.0% — the pattern of someone who eats at a lot of different presentations. Among primary care clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 338 payments — averaging $18.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$1K
- Novo Nordisk$872
- Lilly USA, LLC$592
- Amgen$543
- AstraZeneca$532
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$468
- plus $2K from 18 others
What the payments were for
- Food & beverage$6,317100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 49 | $1,076 |
| Novo Nordisk | 48 | $872 |
| Lilly USA, LLC | 31 | $592 |
| Amgen | 33 | $543 |
| AstraZeneca | 28 | $532 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 33 | $468 |
| Exact Sciences | 14 | $410 |
| Pfizer | 30 | $403 |
| AbbVie | 23 | $388 |
| E.r. Squibb & Sons, L.L.C. | 13 | $293 |
| Boehringer Ingelheim | 10 | $160 |
| Merck | 4 | $90 |
| Axsome Therapeutics, Inc. | 3 | $86 |
| Cequr Corporation | 2 | $66 |
| Phathom Pharmaceuticals, Inc. | 3 | $52 |
| Ascensia Diabetes Care US Inc. | 2 | $47 |
| Novartis | 2 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $47 |
| Esperion Therapeutics, Inc. | 2 | $34 |
| Verona Pharma, Inc. | 1 | $31 |
| ANI Pharmaceuticals, Inc. | 1 | $24 |
| Dexcom, Inc. | 1 | $21 |
| Biogen | 1 | $20 |
| Inspire Medical Systems, Inc. | 1 | $14 |
How this compares
$6,317 in reported general payments places this provider in the 90th percentile of 300 primary care providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 35 | $63,073 |
| EliquisApixaban | 53 | $52,967 |
| JardianceEmpagliflozin | 33 | $47,731 |
| TrulicityDulaglutide | 19 | $44,262 |
| MounjaroTirzepatide | 15 | $21,532 |
| LinzessLinaclotide | 14 | $9,505 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 22 | $3,131 |
| Rosuvastatin Calcium | 109 | $1,910 |
| Atorvastatin Calcium | 109 | $1,829 |
| Gabapentin | 115 | $1,658 |
| Diclofenac Sodium | 17 | $1,471 |
| Montelukast Sodium | 42 | $1,318 |
| Metoprolol Succinate | 73 | $1,178 |
| Escitalopram Oxalate | 50 | $981 |
| Pantoprazole Sodium | 60 | $917 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $592 | $65,79434 claims |
| Novo NordiskOzempic | $872 | $63,07335 claims |
| PfizerEliquis | $403 | $52,96753 claims |
| Boehringer IngelheimJardiance | $160 | $47,73133 claims |
| AbbVieLinzess | $388 | $9,50514 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 300 primary care providers in Pennsylvania.
Other primary care in New Cumberland
- Andrea MauriceNew Cumberland$11K
- Kersten ReiderMount Penn$121K
- Teresa GiamboyPhiladelphia$21K
- Nicole IlgenfritzBethel Park$18K
- Galyna VorokhibPhiladelphia$12K
- Melissa BeansWarrington$12K
- Mollie McGuireJohnstown$11K
- Kendell SoglieroSmithfield$9K
- Minjung RegerDoylestown$9K
- Mackenzie HouserMedia$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.